Status:

RECRUITING

Antiretroviral Therapy for Acute and Chronic HIV Infection

Lead Sponsor:

SEARCH Research Foundation

Collaborating Sponsors:

ViiV Healthcare

Conditions:

Acute HIV Infection

Chronic HIV Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose for this protocol is to provide safe and effective standard ART to SEARCH 010 and SEARCH 013 participants. Participants are enrolled in an acute HIV infection study (SEARCH 010 protocol: '...

Detailed Description

To compare systemic and tissue compartments (genital secretion, CNS, gut and lymph node) outcomes among individuals who initiate HIV treatment during acute vs. chronic HIV infection. The outcomes will...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years old
  • Enrolled in the SEARCH 010 or 013 protocols with documentation of acute or chronic protocol defined HIV-1 infection and chooses to initiate or continue ART
  • Understand the study and sign informed consent form. Persons who cannot read will have the consent form read and explained to them by a member of the study staff and they can give informed consent by using their thumb print
  • Availability for follow-up for the planned study duration

Exclusion

  • 1\. Persons who have a history of a medical or psychiatric disorder by investigator's interview and physical examination according to standard practices, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.

Key Trial Info

Start Date :

May 13 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2033

Estimated Enrollment :

900 Patients enrolled

Trial Details

Trial ID

NCT00796263

Start Date

May 13 2009

End Date

June 1 2033

Last Update

June 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of HIV Research and Innovation

Bangkok, Thailand, 10330